Staphylococcus aureus ( S.aureus ) on a respiratory sample from a patient with cystic fibrosis - Management of |
Publication: 22/12/2016 |
Next review: 30/01/2026 |
Clinical Guideline |
CURRENT |
ID: 4865 |
Approved By: Improving Antimicrobial Prescribing Group |
Copyright© Leeds Teaching Hospitals NHS Trust 2023 |
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated. |
The Management of Staphylococcus aureus (S.aureus) on a respiratory sample from a patient with cystic fibrosis
|
Provenance
Record: | 4865 |
Objective: | To improve the diagnosis and management of Staphylococcal aureus and infection in patients with cystic fibrosis. To provide evidence-based recommendations for appropriate diagnosis, investigation and management of Staphylococcal aureus infection in patients with cystic fibrosis. |
Clinical condition: | Cystic fibrosis; S.aureus; |
Target patient group: | Patients with cystic fibrosis |
Target professional group(s): | Secondary Care Doctors Pharmacists |
Adapted from: |
Evidence base
References and Evidence levels:
A. Meta-analyses, randomised controlled trials/systematic reviews of RCTs
B. Robust experimental or observational studies
C. Expert consensus.
D. Leeds consensus. (where no national guidance exists or there is wide disagreement with a level C recommendation or where national guidance documents contradict each other)
Aktas N. Panton-Valentine leukocidin and biofilm production of Staphylococcus aureus isolated from respiratory tract. J Infect Dev Ctries 2013; 7(11):888-891. PMID: 24240049
Armstrong DS, Grimwood K, Carzino R, et al. Lower respiratory tract infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995; 310: 1571-1572. PMID: 7787647
Besier S et al. Prevalence and Clinical Significance of Staphylococcus aureus
Small-Colony Variants in Cystic Fibrosis Lung Disease. Journal of Clinical Microbiology, Jan. 2007, p. 168–172. PMID: 17108072
Chmiel J et al 2014. Antibiotic Management of Lung Infections in Cystic Fibrosis
I. The Microbiome, Methicillin-Resistant Staphylococcus aureus, Gram-Negative
Bacteria, and Multiple Infections. Ann Am Thorac Soc. 2014 Sep . PMID: 25102221
Doring G, Hoiby N; Consensus Study Group. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004; 3: 67-91. PMID: 15463891
Garske LA, Kidd TJ, Gan R, et al. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect 2004; 56: 208-214. PMID: 15003669
Goerke C, Kraning K, Stern M, et al. Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients. J Infect Dis 2000; 181: 984-989. PMID: 10720521
Goss CH, Burns JL Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.. Thorax. 2007 Apr;62(4):360-7. Review. PMID: 17387214
Goss C, Marianne S. Muhlebach. Review: Staphylococcus aureus and MRSA in cystic fibrosis. Journal of Cystic Fibrosis 10 (2011) 298–306. PMID: 21719362
Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999-1005. PMID: 12039892
Hoiby N, Frederiksen B: Microbiology of Cystic Fibrosis. In: Hodson ME, Geddes D (Eds) Cystic Fibrosis 2nd Edition; 2000: p 83-108.
Kopp BT, Sarzynski L, Khalfoun S, Hayes D Jr, Thompson R, Nicholson L, Long F, Castile R, Groner J.Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis. Pediatr Pulmonol. 2015 Jan;50(1):25-34. Epub 2014 Mar 9.
PMID: 24610820
Linnane B, Vaish S, Clarke D, O'Sullivan N, McNally P. The findings of a clinical surveillance bronchoalveolar lavage programme in pre-school patients with cystic fibrosis. Pediatr Pulmonol. 2015 Apr;50(4):327-32. PMID: 25408378
Littlewood JM, Littlewood AE, McLaughlin S, et al. 20 years continuous neonatal screening in one hospital; progress of the 37 patients and their families. Pediatr Pulmonol 1995; Suppl 12: 374
Lo, David Kh,Hurley, Matthew N,Muhlebach, Marianne S,Smyth, Alan R. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. The Cochrane database of systematic reviews, vol. 2, p. CD009650. (2015). PMID: 25927091
Macfarlane, M,Leavy, A,McCaughan, J,Fair, R,Reid, A J M. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol. The Journal of hospital infection, vol. 65, no. 3, p. 231-236, 0195-6701 (March 2007). PMID: 17178427
Miall LS, McGinley NT, Brownlee KG, et al. Methicillin resistant Staphylcoccus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child 2001; 84: 160-162. PMID: 11159295
Muhlebach M. Treatment intensity and characteristics of MRSA infection in CF. Journal of Cystic Fibrosis 10 (2011) 201–206. PMID: 21420912
Nadesalingam, Kavitha,Conway, Steven P,Denton, Miles. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, vol. 4, no. 1, p. 49-52, 1569-1993 (March 2005). PMID: 15752681
Nolan G, Moivor P, Levison H, Fleming PC, Corey M, Gold R. Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin.
J Pediatr. 1982 Oct;101(4):626-30. PMID: 6981695
Ramsey BW, Wentz KR, Smith AL, et al. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis 1991; 144:331-337. PMID: 1859056
Rao G, Gaya H, Hodson M. MRSA in Cystic Fibrosis. Journal of Hospital Infection. 1998; 49; 179-191. PMID: 9830589
Rosenbluth DB, Wilson K, Ferkol T, et al. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 2004; 126: 412-419. PMID: 15302726
Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28:321-328. PMID: 10536062
Sagel S et al, Impact Of Psuedomonas and Staphylcoccal Infections on Inflammation and Clinical Status in Young Children With Cystic Fibrosis. J Pediatr. 2009 February; 154(2): 183–188. PMID: 18822427
Saiman L, Siegel J. Cystic Fibrosis Foundation. Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update. Infect Control Hosp Epidemiol. August 2014, vol. 35, no. S1. PMID:25025126
Smyth A, Walters S. Prophylactic antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2014; 3:CD001912. PMID: 25419599
Solís, A,Brown, D,Hughes, J,Van Saene, H K F,Heaf, D P. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatric pulmonology, vol. 36, no. 3, p. 189-195, 8755-6863 (September 2003) PMID: 12910579
Southern KW, Littlewood AE, Littlewood JM. The prevalence and significance of chronic Staphylococcus aureus infection in patients with cystic fibrosis on long term flucloxacillin. In: Escobar H, Baquero CF, Svarez L (Eds.) Clinical Ecology of Cystic Fibrosis. Elsevier Science Publ. 1993: 129-130.
Strandvik B, Hollsing A, Möllby R, Granström M. Antistaphylococcal antibodies in cystic fibrosis. Infection. 1990 May-Jun;18(3):170-2. PMID: 2365469
Thomas SR, Gyi KM, Gaya H, et al. Methicillin Resistant Staphylcoccus aureus: impact at a national cystic fibrosis centre Journal of Hospital Infection 1998; 40:203-209. PMID: 9830591
UK CF Trust Infection Control Working Group MRSA document 41 section 6.1
Vanderhelst, Eef,De Wachter, Elke,Willekens, Julie,Piérard, Denis,Vincken, Walter,Malfroot, Anne. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, vol. 12, no. 6, p. 662-666 (December 2013) PMID: 23706641
Approved By
Improving Antimicrobial Prescribing Group
Document history
LHP version 1.0
Related information
Appendix 1: Drug doses
Oral anti-staphylococcal antibiotics | |||
Drug |
Paediatric dose |
Adult dose |
Notes |
Doxycycline 50mg, 100mg capsules. |
>12years: |
100mg twice daily. |
|
Flucloxacillin |
1month-18years: |
1 Gram four times a day |
|
Rifampicin |
Child 1–11 months Child 1–17 years |
Adult |
Renal function should be checked before treatment. |
Sodium fusidate/fusidic acid 250mg/5mL fusidic acid |
Suspension Tablets |
Adult -suspension Adult |
Dose equivalence and conversion |
Equity and Diversity
The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.